Breed distribution of the nt230(del4) MDR1 mutation in dogs

Veterinary Journal

Volumn 189, Issue 1, 2011, Pages 67-71

  Gramer, Irina ^a   Leidolf, Regina ^a   Döring, Barbara ^a   Klintzsch, Stefanie ^a   Krämer, Eva Maria ^b   Yalcin, Ebru ^c   Petzinger, Ernst ^a   Geyer, Joachim ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

^b Collie Revue ^*  (Germany)

^c ULUDAG UNIVERSITY   (Turkey)

Author keywords

Dog; Drug sensitivity; Ivermectin; MDR1; P glycoprotein

Indexed keywords

MULTIDRUG RESISTANCE PROTEIN 1;

ARTICLE; BREED; CONTROLLED STUDY; DOG; GENE FREQUENCY; GENE MUTATION; GENOTYPE; GERMANY; HETEROZYGOSITY; HOMOZYGOSITY; MDR1 GENE; MOLECULAR PHYLOGENY; NONHUMAN;

ANIMALS; DOGS; DRUG RESISTANCE, MULTIPLE; GENE FREQUENCY; GENES, MDR; GENETIC TESTING; GENOTYPE; GERMANY; MUTATION; P-GLYCOPROTEIN; SPECIES SPECIFICITY;

ANIMALIA; BOS; CANIS FAMILIARIS;

EID: 79959267428     PISSN: 10900233     EISSN: 15322971     Source Type: Journal    
DOI: 10.1016/j.tvjl.2010.06.012     Document Type: Article

References (23)

1. Baars C., Leeb T., von Klopmann T., Tipold A., Potschka H. Allele-specific polymerase chain reaction diagnostic test for the functional MDR1 polymorphism in dogs. The Veterinary Journal 2008, 177:394-397.
2. Cordon-Cardo C., O'Brien J.P., Boccia J., Casals D., Bertino J.R., Melamed M.R. Expression of the multidrug resistance gene product (P-glycoprotein) in human normal and tumor tissues. Journal of Histochemistry and Cytochemistry 1990, 38:1277-1287.
3. Fecht S., Wöhlke A., Hamann H., Distl O. Analysis of the canine mdr1-1Δ mutation in the dog breed Elo. Journal of Veterinary Medicine, A, Physiology, Pathology, Clinical Medicine 2007, 54:401-405.
4. Fromm M.F. Importance of P-glycoprotein at blood-tissue barriers. Trends in Pharmacological Sciences 2004, 25:423-429.
5. Geyer J., Döring B., Godoy J.R., Moritz A., Petzinger E. Development of a PCR-based diagnostic test detecting a nt230(del4) MDR1 mutation in dogs: verification in a moxidectin-sensitive Australian Shepherd. Journal of Veterinary Pharmacology and Therapeutics 2005, 28:95-99.
6. Geyer J., Döring B., Godoy J.R., Leidolf R., Moritz A., Petzinger E. Frequency of the nt230(del4) MDR1 mutation in Collies and related dog breeds in Germany. Journal of Veterinary Pharmacology and Therapeutics 2005, 28:545-551.
7. Geyer J., Klintzsch S., Meerkamp K., Wöhlke A., Distl O., Moritz A., Petzinger E. Detection of the nt230(del4) MDR1 mutation in White Swiss Shepherd dogs: case reports of doramectin toxicosis, breed predisposition, and microsatellite analysis. Journal of Veterinary Pharmacology and Therapeutics 2007, 30:482-485.
8. Hugnet C., Bentjen S.A., Mealey K.L. Frequency of the mutant MDR1 allele associated with multidrug sensitivity in a sample of Collies from France. Journal of Veterinary Pharmacology and Therapeutics 2004, 27:227-229.
9. Kawabata A., Momoi Y., Inoue-Murayama M., Iwasaki T. Canine mdr1 gene mutation in Japan. Journal of Veterinary Medical Sciences 2005, 67:1103-1107.
10. Klintzsch S., Meerkamp K., Döring B., Geyer J. Detection of the nt230(del4) MDR1 mutation in dogs by a fluorogenic 5′ nuclease TaqMan allelic discrimination method. The Veterinary Journal 2009, 185:272-277.
11. Martinez M., Modric S., Sharkey M., Troutman L., Walker L., Mealey K. The pharmacogenomics of P-glycoprotein and its role in veterinary medicine. Journal of Veterinary Pharmacology and Therapeutics 2008, 31:285-300.
12. Mealey K.L. Therapeutic implications of the MDR-1 gene. Journal of Veterinary Pharmacology and Therapeutics 2004, 27:257-264.
13. Mealey K.L. Canine ABCB1 and macrocyclic lactones: heartworm prevention and pharmacogenetics. Veterinary Parasitology 2008, 158:215-222.
14. Mealey K.L., Meurs K.M. Breed distribution of the ABCB1-1Δ (multidrug sensitivity) polymorphism among dogs undergoing ABCB1 genotyping. Journal of the American Veterinary Medical Association 2008, 233:921-924.
15. Mealey K.L., Bentjen S.A., Gay J.M., Cantor G.H. Ivermectin sensitivity in collies is associated with a deletion mutation of the mdr1 gene. Pharmacogenetics 2001, 11:727-733.
16. Mealey K.L., Bentjen S.A., Waiting D.K. Frequency of the mutant MDR1 allele associated with ivermectin sensitivity in a sample population of Collies from the northwestern United States. American Journal of Veterinary Research 2002, 63:479-481.
17. Mealey K.L., Munyard K.A., Bentjen S.A. Frequency of the mutant MDR1 allele associated with multidrug sensitivity in a sample of herding breed dogs living in Australia. Veterinary Parasitology 2005, 10:193-196.
18. Neff M.W., Robertson K.R., Wong A.K., Safra N., Broman K.W., Slatkin M., Mealey K.L., Pedersen N.C. Breed distribution and history of canine mdr1-1Δ, a pharmacogenetic mutation that marks the emergence of breeds from the collie lineage. Proceedings of the National Academy of Sciences of the United States of America 2004, 101:11725-11730.
19. Parker H.G., Kim L.V., Sutter N.B., Carlson S., Lorentzen T.D., Malek T.B., Johnson G.S., DeFrance H.B., Ostrander E.A., Kruglyak L. Genetic structure of the purebred domestic dog. Science 2004, 304:1160-1164.
20. Pulliam J.D., Seward R.L., Henry R.T., Steinberg S.A. Investigating ivermectin toxicity in Collies. Veterinary Medicine 1985, 80:33-40.
21. Seward R.L. Reactions in dogs given ivermectin. Journal of the American Veterinary Medical Association 1983, 183:493.
22. Tappin, S.W., Goodfellow, M.R., Peters, I.R., Day, M.J., Hall, E.J., Bentjen, S.A., Mealey, K.L., 2008. Frequency of the mutant MDR1 allele associated with multidrug sensitivity in dogs in the United Kingdom. In: BSAVA Congress, Scientific Proceedings: Veterinary Programme, 83/49.
23. Thiebaut F., Tsuruo T., Hamada H., Gottesman M.M., Pastan I., Willingham M.C. Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues. Proceedings of the National Academy of Sciences of the United States of America 1987, 84:7735-7738.